- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Report
- January 2022
- 200 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- January 2022
- 60 Pages
Global
From €3794EUR$3,950USD£3,266GBP
- Report
- January 2022
- 60 Pages
Global
From €3794EUR$3,950USD£3,266GBP
- Report
- May 2024
- 185 Pages
From €4706EUR$4,900USD£4,052GBP
- Drug Pipelines
- November 2020
- 93 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- January 2024
- 100 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- September 2022
- 54 Pages
Global
From €1921EUR$2,000USD£1,654GBP
The Gastritis Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat a variety of gastrointestinal disorders. Gastritis Drugs are used to treat gastritis, an inflammation of the stomach lining. These drugs can reduce symptoms such as abdominal pain, nausea, and vomiting, as well as reduce the risk of ulcers and bleeding. Commonly used Gastritis Drugs include proton pump inhibitors, histamine-2 receptor antagonists, and antibiotics.
Some companies in the Gastritis Drug market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and GlaxoSmithKline. Other companies include AbbVie, Merck, and Novartis. Show Less Read more
